In the most successful billion-dollar IPO since Corvis’ 135% first-day pop in July 2000, Twitter jumped 73% on Thursday after raising $1.8 billion at $26 per share, far above its initial $17 to $20 range. Twitter’s (TWTR) 60% gain through Friday...read more
Karyopharm Therapeutics, an early-stage biotech developing treatments for cancer by targeting nuclear transport, raised $109 million by offering 6.8 million (up from 5.7 million) shares at $16, the high end of the range of $14 to $16. Karyopharm Therapeutics...read more
Karyopharm Therapeutics, a clinical-stage biotech developing treatments for cancer and other major diseases, announced terms for its IPO on Monday. The Natick, MA-based company plans to raise $85 million by offering 5.7 million shares at a price range of $14 to...read more
US IPO Recap: Twitter shines in a busy but shaky 13 IPO week
In the most successful billion-dollar IPO since Corvis’ 135% first-day pop in July 2000, Twitter jumped 73% on Thursday after raising $1.8 billion at $26 per share, far above its initial $17 to $20 range. Twitter’s (TWTR) 60% gain through Friday...read more
Karyopharm Therapeutics prices upsized IPO at $16, the high end of the range
Karyopharm Therapeutics, an early-stage biotech developing treatments for cancer by targeting nuclear transport, raised $109 million by offering 6.8 million (up from 5.7 million) shares at $16, the high end of the range of $14 to $16. Karyopharm Therapeutics...read more
15 US IPOs planned for the week of Nov 4
The following IPOs are expected to price this week: Arc Logistics Partners LP (ARCX), a Lightfoot Capital-backed MLP that owns crude oil and refined product terminals, ...read more
Cancer biotech Karyopharm Therapeutics sets terms for $85 million IPO
Karyopharm Therapeutics, a clinical-stage biotech developing treatments for cancer and other major diseases, announced terms for its IPO on Monday. The Natick, MA-based company plans to raise $85 million by offering 5.7 million shares at a price range of $14 to...read more